AVIEW vs VitalConnect VitalPatch

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AVIEW

by Coreline Soft Co.

VitalConnect VitalPatch

by VitalConnect

AI Verdict

AVIEW is designed for diagnostic support and workflow optimization through the analysis of CT scan images, particularly for lung and cardiac conditions. In contrast, VitalConnect VitalPatch provides real-time, continuous physiological monitoring via a wearable biosensor for vital signs and cardiac arrhythmias, focusing on remote and in-hospital patient surveillance. While both leverage AI in cardiology, they serve distinct purposes: AVIEW for imaging-based diagnosis and VitalPatch for continuous physiological data monitoring.

Choose AVIEW if…

Choose AVIEW if your primary need is advanced AI-driven analysis of CT scans for the early detection, diagnosis, and monitoring of lung conditions or coronary artery calcification. This tool is ideal for radiology departments seeking to enhance diagnostic precision and automate workflows for comprehensive imaging reports and follow-up management.

View AVIEW →

Choose VitalConnect VitalPatch if…

Choose VitalConnect VitalPatch if you require real-time, continuous monitoring of vital signs and cardiac arrhythmias for patients, both in-hospital and remotely. This wearable biosensor solution is best suited for healthcare professionals needing to track patient physiological data over extended periods, enabling proactive intervention and efficient remote patient management.

View VitalConnect VitalPatch →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AVIEW	VitalConnect VitalPatch
Pricing	Subscription; one-off payment	Contact for pricing
Deployment	Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker)	Cloud-based with wearable biosensor and patient-carried relay devices (VistaPhone/VistaTablet).
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

VitalConnect VitalPatch

VitalConnect VitalPatch offers superior usability due to its patient-centric design as a comfortable, disposable wearable biosensor that allows for freedom of movement and easy self-application. While AVIEW streamlines radiology workflows for clinicians, VitalPatch's focus on both patient comfort and streamlined clinician access to real-time data from a simple wearable makes it more broadly usable across different care settings and for patients.

Clinical Value

Tie

Both tools offer significant and validated clinical value in their specialized domains. AVIEW provides advanced AI for diagnostic precision and efficiency in thoracic imaging, with extensive real-world adoption and proven impact on workflow and detection. VitalPatch delivers critical real-time, continuous physiological monitoring and AI-driven arrhythmia detection, with evidence of accuracy and reduction in false alarms, directly impacting acute and remote patient management. Their distinct applications prevent a clear winner in overall clinical value.

Pricing & Value

VitalConnect VitalPatch

While AVIEW provides clear pricing models, VitalConnect VitalPatch offers a more compelling value proposition by being widely covered by Medicare and private insurers, which directly addresses patient access and provider reimbursement. The potential for significant cost reduction in acute care and the availability of a patient financial assistance program further enhance its overall value.

Enterprise Readiness

AVIEW

AVIEW demonstrates stronger enterprise readiness due to its highly flexible deployment options, including on-premise and hybrid solutions, which cater to diverse IT infrastructures and data governance requirements in large healthcare systems. Its deep integration capabilities with existing radiology systems (PACS/RIS/CIS) and adherence to standards like IHE and FHIR ensure seamless adoption into complex enterprise workflows.

Innovation

Tie

Both tools exhibit significant innovation in their respective fields. AVIEW pushes the boundaries of AI in diagnostic imaging with its integrated multi-disease analysis, advanced quantitative tools, and AI-evaluating-AI capabilities. VitalConnect VitalPatch is innovative in its compact, multi-parameter wearable biosensor technology for continuous, real-time remote monitoring and AI-driven arrhythmia detection, offering a unique solution for patient care outside traditional settings.

Support & Docs

VitalConnect VitalPatch

VitalConnect VitalPatch offers more comprehensive and transparent support and documentation, including dedicated phone and email contacts for various issues (technical, billing, customer service), extensive Instructions for Use, QuickStart Guides, and in-app guided help for patients. The provision of a 24/7 staffed monitoring center for cardiac support further enhances its support ecosystem.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AVIEW	VitalConnect VitalPatch
Name	AVIEW	VitalConnect VitalPatch
Company	Coreline Soft Co.	VitalConnect
Primary Function	AI platform for early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans.	Wearable biosensor and cloud-based platform for real-time, continuous monitoring of vital signs and cardiac arrhythmias.
Key Features (Examples)	AI-powered lung nodule detection and characterization; Emphysema quantification; Coronary artery calcium (CAC) scoring; 3D visualizations; Workflow automation.	Wearable biosensor for continuous monitoring; Real-time streaming of up to 11 vital signs including live ECG; Detection of 21 cardiac arrhythmias; 7-day continuous wear period.
Categories	Cardiology AI, Oncology AI, Radiology & Imaging AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Critical Care, Emergency Medicine

Videos

Demos, reviews, and walkthroughs featuring AVIEW and VitalConnect VitalPatch.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and what is the depth of their integration with EHR systems?

AVIEW is designed to streamline radiology workflows by integrating with PACS/RIS/CIS, offering automated analysis and comprehensive reports that can be incorporated into patient records. It supports follow-up registration and nodule matching for serial CT scans, fitting into diagnostic and monitoring pathways. VitalPatch integrates real-time vital sign and arrhythmia data from its wearable biosensor into a cloud-based platform (VitalCloud, VistaCenter), which can then be accessed by healthcare professionals. This enables continuous remote patient monitoring and in-hospital care, likely requiring integration points with EHRs for data transfer and alerts.

What are the reported accuracy and sensitivity for the AI algorithms in detecting specific conditions or events relevant to each tool's function?

AVIEW utilizes AI for lung nodule detection and characterization (size, volume, type, location, Lung-RADS score), emphysema quantification, and coronary artery calcium (CAC) scoring, enhancing diagnostic precision from CT scans. For lung nodule detection, AVIEW Lungscreen has shown a per-nodule sensitivity of 50.2% in one study and 97% sensitivity and 76% specificity at 1-FP/scan in another. VitalPatch employs AI algorithms to detect 21 cardiac arrhythmias and continuously monitor up to 11 vital signs, including live ECG, providing real-time data for healthcare professionals.

Beyond the listed specialties, in which specific clinical scenarios or patient populations would each tool provide the most significant clinical value?

AVIEW offers significant value in early detection and monitoring of lung cancer, COPD, and coronary artery disease through CT scan analysis, making it highly relevant for pulmonology, cardiology, and radiology departments focused on screening and disease progression. Its nodule matching and ILD analysis features are particularly useful for long-term follow-up and complex lung conditions. VitalPatch is ideal for continuous, real-time monitoring of patients requiring close observation for cardiac arrhythmias and vital sign fluctuations, especially in critical care, emergency medicine, and remote patient monitoring programs for chronic conditions. Its 7-day wear period and water-resistant design support extended monitoring outside acute settings.

What is the expected learning curve for clinical staff to effectively utilize each tool, and how quickly can a practice expect to realize clinical benefits or time-to-value?

AVIEW provides 3D visualizations and comprehensive PDF reports, suggesting a learning curve for interpreting advanced AI analyses and integrating them into diagnostic reports, but aims to streamline workflows for faster diagnosis and follow-up. Clinical validation for AVIEW 2.0 demonstrated up to 89% faster case throughput and 60% reduction in interpretation time, indicating a quick time-to-value through efficiency gains. VitalPatch involves a wearable biosensor and patient-carried relay devices, requiring staff and patient education for proper application and use. Real-time data streaming is designed to provide immediate clinical insights for timely interventions, contributing to rapid clinical benefit.

How easily can these solutions be scaled for multi-site healthcare systems, and are customer references available to demonstrate successful large-scale implementations?

AVIEW's flexible deployment options, including cloud-based, hybrid, and local solutions, suggest adaptability for multi-site rollouts, allowing organizations to choose the model best suited for their infrastructure. Coreline Soft has proven its ability to efficiently manage cloud-based AI image data and operate large-scale screenings, participating in various European lung cancer screening projects. VitalPatch's cloud-based platform and use of patient-carried relay devices are inherently designed for scalability, facilitating remote patient monitoring across geographically dispersed populations or multiple hospital sites. VitalConnect has deployed more than 100,000 patches across the world, including care facilities such as Hackensack Medical Center and Northwell Health.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring AVIEW or VitalConnect VitalPatch

Backers

Who funded each tool's parent company.